Skip to main content
. 2025 Jun 15;15(6):2733–2749. doi: 10.62347/QCSN6467

Table 1.

Comparison of baseline characteristics between the comorbidity group and COPD group

Variable Comorbidity Group (n=133) COPD Group (n=91) Z/t/χ2 Value P-Value
Age 66.00 (63.00, 71.00) 64.00 (62.50, 66.00) 3.505 <0.001
    ≥65 years 89 41 9.259 0.002
    <65 years 47 50
Gender 6.351 0.012
    Male 122 73
    Female 11 18
BMI (kg/m2) 22.91 (3.20) 22.90 (3.35) 0.014 0.989
    <18.5 11 10 0.569 0.752
    18.5-24 75 48
    >24 47 33
COPD Duration (years) 11.00 (7.00, 16.00) 8.00 (5.00, 12.00) 3.197 0.001
    <10 55 56 11.038 0.004
    45585 65 33
    >20 13 2
Residence 0.316 0.574
    Urban 65 41
    Rural 68 50
Smoking History 7.63 0.006
    Present 108 59
    Absent 25 32
Drinking History 1.436 0.231
    Present 29 14
    Absent 104 77
Diabetes History 0.031 0.861
    Present 8 6
    Absent 125 85
Acute Exacerbation in Past Year 1.632 0.201
    Present 90 54
    Absent 43 37
Corticosteroid Treatment 6.065 0.014
    Present 20 26
    Absent 113 65
GOLD Staging 24.804 <0.001
    I 18 2
    II 79 37
    III 34 46
    IV 2 6

Note: BMI: Body Mass Index, COPD: Chronic Obstructive Pulmonary Disease, GOLD: Global Initiative for Chronic Obstructive Lung Disease.